Supplementary Tables
. Supplementary precision data -derivatized amino acids.…………………………………….. 11 Table S6 . Supplementary precision data -underivatized isoleucine and allo-Ile ……………………….. 12 Table S12 . Unlabeled isoleucine and allo-isoleucine in plasma…………………………………….…… 19 Table S13 . Matrix-specific precision and signal suppression results…………………………………..… 20 Table S14 . Lipemia mixing studies (plasma)……………………………………………………….…… 25 15 N) labeled AA analogs (I.S.), underivatized leucine derivatives, and underivatized isotopically labeled leucine derivatives, the latter two required for allo-Ile analysis and Ile measurement in the presence of allo-Ile. Phosphorylethanolamine is detectible but is not quantified or reported. b Mass transitions (Q1/Q3) for target amino acids were provided by the kit manufacturer. Mass transitions for the analogous amino acid internal standards ( 13 C, 15 N-labeled) were calculated based on the expected number of isotopically labeled carbon and nitrogen atoms in the native AA structure. Mass transition for underivatized, 13 C, 15 N-labeled leucine derivatives ("uLeu deriv. (I.S.)") were determined empirically via direct infusion experiment. c Chromatography peak center. d Time window to include target as part of the SRM scanning, centered on the retention time. 
Rec. 3 For Ala, Asn, Asp, Cit, Cys, Glu, Gly, Ile, Leu, Met, Phe, Pro, Ser, Tau, Thr, Tyr, and Val, %plasma (v/v) equaled either 90% or 85% across all levels. For Arg, His, homocystine (HCY), Lys, Orn, and Trp, %plasma = 96%, 96%, 96%, 85%, and 50% for levels 1 to 5, respectively. For argininosuccinic acid (ASA) and Gln %plasma ranged from 86 to 98%. Homocitrulline spiked plasmas were >91% plasma. For all amino acids except Gln, expected concentration (Exp.) was determined by extrapolation based on LCMS measurement of the unspiked plasma. For Gln expected concentration equaled ion-exchange chromatography measurement for that sample (LCMS measurement of unspiked plasma was not performed). Additional high levels were tested for ASA -1142.9 M (Rec. = 101.3%,) and 1428.57 M (rec. = 107.4%), as well as for Gln -1701.0 M (Rec. =92.8%) and 1771.5 M (Rec. = 99.2%). Expected concentrations were extrapolated from LCMS result for unspiked/undiluted specimen. Spiked urine specimens (Levels 1-7) consisted of 50, 75, 98, 90, 90, 80 , and 50% urine. 11 Samples 3 and 6-9 (100% plasma) results based on IEX analysis of patient plasma (Maple Syrup Urine Disease patient plasmas). Additional samples 1, 2, 4, and 5 concentrations extrapolated based on sample spiking with standard or water (50, 99, 75, 50% plasma, respectively). -specific precision and signal suppression results (Page 1 of 5) .
TESTING IN PLASMA
Samples consist of pooled plasma, urine, or CSF, constituting equal volume mixtures from 5-6 separate patients. Samples were analyzed in triplicate and run in 5 separate batches over the course of approximately 1 week, using fresh aliquots of plasma, urine, and CSF stored at -80C for each run. The IEX reference value reflects single analysis of an aliquot of pooled sample using ion-exchange chromatography (Biochrom Analyzer). Differences in results between the platforms will depend on matrix-specific features and day-to-day performance, including but not limited to quality of analyte separation during IEX analysis and underlying interferents in the pooled samples affecting optical-based detection. Data for aspartic acid and proline are shown for urine due to relevance of the C13,N15 internal standards of these targets to ornithine (Pro closest in retention time, Asp appeared most similar overall to Orn as internal control during initial testing). In the matrix suppresion analysis, suppression = (STD I.S. Intensity -Replicate I.S. Intensity) / (STD I.S. Intensity). Run 2 was a single outlier for which suppression of internal standard signal in 0.1 M HCl compared to matrix was not observed. For the remaining runs, suppression was generally greater in the pooled plasma sample compared to urine and CSF. Sample preparation error (*) resulted in no chromatography peaks in one CSF sample analysis (Run 2, Replicate C). Table S13 . Matrix-specific precision and signal suppression results (Page 2 of 5).
ALANINE IN PLASMA (IEX REFERENCE VALUE = 421.4 uM) I.S. ALANINE C13, N15 (MSK-A2)
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TESTING IN PLASMA (CONTINUED)
Samples consist of pooled plasma, urine, or CSF, constituting equal volume mixtures from 5-6 separate patients. Samples were analyzed in triplicate and run in 5 separate batches over the course of approximately 1 week, using fresh aliquots of plasma, urine, and CSF stored at -80C for each run. The IEX reference value reflects single analysis of an aliquot of pooled sample using ion-exchange chromatography (Biochrom Analyzer). Differences in results between the platforms will depend on matrix-specific features and day-to-day performance, including but not limited to quality of analyte separation during IEX analysis and underlying interferents in the pooled samples affecting optical-based detection. Data for aspartic acid and proline are shown for urine due to relevance of the C13,N15 internal standards of these targets to ornithine (Pro closest in retention time, Asp appeared most similar overall to Orn as internal control during initial testing). In the matrix suppresion analysis, suppression = (STD I.S. Intensity -Replicate I.S. Intensity) / (STD I.S. Intensity). Run 2 was a single outlier for which suppression of internal standard signal in 0.1 M HCl compared to matrix was not observed. For the remaining runs, suppression was generally greater in the pooled plasma sample compared to urine and CSF. Sample preparation error (*) resulted in no chromatography peaks in one CSF sample analysis (Run 2, Replicate C). Table S13 . Matrix-specific precision and signal suppression results (Page 3 of 5).
Samples consist of pooled plasma, urine, or CSF, constituting equal volume mixtures from 5-6 separate patients. Samples were analyzed in triplicate and run in 5 separate batches over the course of approximately 1 week, using fresh aliquots of plasma, urine, and CSF stored at -80C for each run. The IEX reference value reflects single analysis of an aliquot of pooled sample using ion-exchange chromatography (Biochrom Analyzer). Differences in results between the platforms will depend on matrix-specific features and day-to-day performance, including but not limited to quality of analyte separation during IEX analysis and underlying interferents in the pooled samples affecting optical-based detection. Data for aspartic acid and proline are shown for urine due to relevance of the C13,N15 internal standards of these targets to ornithine (Pro closest in retention time, Asp appeared most similar overall to Orn as internal control during initial testing). In the matrix suppresion analysis, suppression = (STD I.S. Intensity -Replicate I.S. Intensity) / (STD I.S. Intensity). Run 2 was a single outlier for which suppression of internal standard signal in 0.1 M HCl compared to matrix was not observed. For the remaining runs, suppression was generally greater in the pooled plasma sample compared to urine and CSF. Sample preparation error (*) resulted in no chromatography peaks in one CSF sample analysis (Run 2, Replicate C). 
